State Street Corp Jazz Pharmaceuticals PLC Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, State Street Corp holds 1,946,273 shares of JAZZ stock, worth $247 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,946,273

Previous 2,017,309 3.52%

Holding current value

$247 Million

Previous $215 Million 0.75%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.57 - $116.37 $7.14 Million - $8.27 Million	-71,036 Reduced 3.52%	1,946,273 $217 Million
Q2 2024 Aug 14, 2024	SELL	$103.94 - $118.98 $46.2 Million - $52.9 Million	-444,826 Reduced 18.07%	2,017,309 $215 Million
Q1 2024 May 15, 2024	BUY	$115.19 - $132.77 $4.72 Million - $5.44 Million	41,010 Added 1.69%	2,462,135 $296 Million
Q4 2023 Feb 14, 2024	BUY	$114.26 - $136.0 $11 Million - $13.1 Million	96,077 Added 4.13%	2,421,125 $298 Million
Q3 2023 Nov 14, 2023	SELL	$122.0 - $145.31 $5.78 Million - $6.88 Million	-47,347 Reduced 2.0%	2,325,048 $301 Million
Q2 2023 Aug 14, 2023	BUY	$122.5 - $147.16 $5.23 Million - $6.28 Million	42,703 Added 1.83%	2,372,395 $294 Million
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $3.3 Million - $3.95 Million	24,635 Added 1.07%	2,329,692 $341 Million
Q4 2022 Feb 14, 2023	BUY	$129.72 - $159.85 $2.01 Million - $2.47 Million	15,476 Added 0.68%	2,305,057 $367 Million
Q3 2022 Nov 15, 2022	BUY	$126.59 - $161.18 $4.16 Million - $5.29 Million	32,842 Added 1.46%	2,289,581 $305 Million
Q2 2022 Aug 15, 2022	SELL	$141.59 - $168.66 $12.5 Million - $14.9 Million	-88,496 Reduced 3.77%	2,256,739 $352 Million
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $1.85 Million - $2.3 Million	14,293 Added 0.61%	2,345,235 $365 Million
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $541,932 - $658,574	4,521 Added 0.19%	2,330,942 $297 Million
Q3 2021 Nov 15, 2021	SELL	$128.64 - $184.79 $9.34 Million - $13.4 Million	-72,642 Reduced 3.03%	2,326,421 $303 Million
Q2 2021 Aug 16, 2021	BUY	$160.2 - $186.42 $31.7 Million - $36.9 Million	197,752 Added 8.98%	2,399,063 $426 Million
Q1 2021 May 17, 2021	SELL	$150.19 - $173.5 $8.01 Million - $9.25 Million	-53,307 Reduced 2.36%	2,201,311 $362 Million
Q4 2020 Feb 16, 2021	BUY	$140.71 - $165.05 $13.2 Million - $15.5 Million	93,795 Added 4.34%	2,254,618 $372 Million
Q3 2020 Nov 10, 2020	BUY	$105.46 - $144.13 $70 Million - $95.7 Million	663,824 Added 44.34%	2,160,823 $308 Million
Q2 2020 Aug 14, 2020	SELL	$95.68 - $121.88 $991,627 - $1.26 Million	-10,364 Reduced 0.69%	1,496,999 $165 Million
Q1 2020 May 11, 2020	BUY	$87.74 - $152.74 $132 Million - $230 Million	1,507,363 New	1,507,363 $150 Million

Others Institutions Holding JAZZ

# of Institutions

511

Shares Held

57.7M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.94B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Jazz Pharmaceuticals PLC Transaction History